Drugs in Development
All Data
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Lead Product(s): GDD3898
Therapeutic Area: Nutrition and Weight Loss Product Name: Undisclosed
Highest Development Status: Phase II Product Type: Undisclosed
Partner/Sponsor/Collaborator: Maxim Merchant Capital
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Series A Financing March 03, 2020
Details:
The financing will support the development of its lead therapeutic candidate GDD3898.
Market Place
Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace
